Highly efficient synthesis of 2-mercaptobenzothiazole derivatives in water: metal sulfide–disulfide dynamic interchange reaction
作者:Chunqing Lou、Ning Zhu、Ronghua Fan、Hailong Hong、Limin Han、Jianbin Zhang、Quanling Suo
DOI:10.1039/c6gc03053j
日期:——
A convenient and efficient method for the synthesis of 2-mercaptobenzothiazoles from disulfide and CS2 mediated by metal sulfide in water is described. This synthetic methodology could be used to prepare...
Accelerated reduction and solubilization of elemental sulfur by 1,2-aminothiols
作者:Jonathan T. Stoffel、Kimberly T. Riordan、Emily Y. Tsui
DOI:10.1039/d1cc05242j
日期:——
Nucleophilic 1,2-aminothiol compounds readily reduce typically-insoluble elementalsulfur to polysulfides in both water and nonpolar organic solvents. The resulting anionic polysulfide species are stabilized through hydrogen-bonding interactions with the proximal amine moieties. These interactions can facilitate sulfur transfer to alkenes.
COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPOXIC OR ISCHEMIC INJURY
申请人:Wintner Edward A.
公开号:US20100130555A1
公开(公告)日:2010-05-27
A method for treating or preventing injury of a biological material exposed to hypoxic or ischemic conditions comprising contacting the biological material with an effective amount of a compound is disclosed. The compound has the following structure (I):
R
1
—(S)
n
—R
2
(I)
or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof, wherein R
1
, R
2
, and n are as defined herein. Compounds, methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
US8202997B2
申请人:——
公开号:US8202997B2
公开(公告)日:2012-06-19
[EN] COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPOXIC OR ISCHEMIC INJURY<br/>[FR] COMPOSITIONS ET PROCÉDÉS POUR TRAITER OU PRÉVENIR UNE LÉSION HYPOXIQUE OU ISCHÉMIQUE
申请人:IKARIA INC
公开号:WO2010045582A2
公开(公告)日:2010-04-22
A method for treating or preventing injury of a biological material exposed to hypoxic or ischemic conditions comprising contacting the biological material with an effective amount of a compound is disclosed. The compound has the following structure (I): R1_(S)n-R2 or a stereoisomer, pharmaceutically acceptable salt or prodrug thereof, wherein R1, R2, and n are as defined herein. Compounds, methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.